Sino Biological | 2023-2024年最新流感疫苗株重組蛋白 2023.07.10 Sino Biological Featured Products Featured Cytokines CRO Services 世界衛生組織WHO公佈2023-2024年北半球流感疫苗的流感預測建議。Sino Biological為了支持流感疫苗相關的研究， 發佈2023-2024流感疫苗株一系列的重組抗原。 Sino Biological有著全球最大的病毒抗原庫ProVir®，提供了一系列重組流感抗原產品，包括近年來WHO推薦所有疫苗株的 Hemagglutinin (HA), Neuraminidase (NA) and Nucleoprotein (NP) 蛋白，此外也可以提供大量針對流感抗原的單株抗體，可用於相關檢測和診斷試劑盒的開發。 Antigens for 2023-2024 Influenza Vaccine Strains A/Victoria/4897/2022 (H1N1) A/Darwin/9/2021 (H3N2) Recommended for egg-based (quadrivalent, trivalent) vaccine Recommended for egg-based, cell- or recombinant-based (quadrivalent, trivalent) vaccine HA: 40938-V08H (pre-order) HA: 40859-V08B 40938-V08B (pre-order) 40859-V08H NA: 40939-V08B (pre-order) NA: 40860-V08B 40941-V08B (pre-order) NP: 40858-V08B B/Austria/1359417/2021 (B/Victoria lineage) A/Wisconsin/67/2022 (H1N1) Recommended for egg-based, cell- or recombinant-based (quadrivalent, trivalent) vaccine Recommended for cell- or recombinant-based (quadrivalent, trivalent) vaccine HA: 40862-V08B HA: 40940-V08H (pre-order) 40862-V08H 40940-V08B (pre-order) NA: 40863-V08B NA: 40941-V08B (pre-order) NP: 40861-V08B NP: 40942-V08B (pre-order) B/Phuket/3073/2013 (B/Yamagata lineage) Recommended for egg-based, cell- or recombinant-based (quadrivalent) vaccine HA: 40498-VNAB, 40498-V08B, 40498-V08H1 NA: 40502-V07B NP: 40500-V08B BACK TO LIST
